• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期精神卫生设施综合网络中精神卫生使用者和工作人员的感染、传播及 COVID-19 结局的流行病学:回顾性观察性基于人群的研究。

Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study.

机构信息

Mental Health Service, Hospital Universitario Virgen del Rocío, Sevilla, Spain; Centro Investigación Biomédica en Red Salud Mental, CIBERSAM, Madrid, Spain; Instituto de Biomedicina de Sevilla (IBiS) HUVR/CSIC/Universidad de Sevilla, Seville, Spain.

Fundación Pública Andaluza para la Integración Social de Personas con Enfermedad Mental (FAISEM), Andalusia, Spain.

出版信息

Schizophr Res. 2023 Apr;254:1-7. doi: 10.1016/j.schres.2023.01.020. Epub 2023 Jan 20.

DOI:10.1016/j.schres.2023.01.020
PMID:36736100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9852313/
Abstract

BACKGROUND

A high Coronavirus Disease 19 (COVID-19) morbidity and mortality have been reported among users and workers of long-term care facilities. The main objective of this work was to explore the prevalence and temporal pattern of COVID-19 in comprehensive network of long-term mental health facilities in Spain. Secondly, we aimed to estimate the effect of having a severe mental health diagnosis on prevalence and COVID-19 outcomes.

METHODS

A cohort of 2552 participants were followed-up over a one-year. Sociodemographic and clinical data related to COVID-19 were recollected using a proforma. Frequency analyses were used to determine the prevalence of COVID-19 disease. Multivariable binary regression models sequentially adjusted by gender and age were employed to explore the potential role of severe mental health diagnosis on COVID-19 outcomes.

RESULTS

Workers had higher risk of testing positive than mental health users (odds ratio [OR] 1.57 [95 % CI 1.01-2.43; p < 0.05] who presented an equivalent risk of testing positive after accounting for age and gender (OR 1.62 [95 % CI 0.98-2.66; p = 0.06].

CONCLUSIONS

The significant lower prevalence of COVID-19 among mental health users could be explained by the measures implemented to prevent COVID-19 as well as by the possible role that antipsychotic treatment could play in the prevention of SARS-CoV-2 infection.

摘要

背景

长期护理机构的使用者和工作人员报告了较高的 2019 冠状病毒病(COVID-19)发病率和死亡率。这项工作的主要目的是探索西班牙综合长期精神卫生设施网络中 COVID-19 的流行情况和时间模式。其次,我们旨在估计严重精神卫生诊断对流行率和 COVID-19 结果的影响。

方法

对 2552 名参与者进行了为期一年的随访。使用表格收集与 COVID-19 相关的社会人口学和临床数据。频率分析用于确定 COVID-19 疾病的流行率。采用多变量二项回归模型,按性别和年龄顺序调整,以探讨严重精神卫生诊断对 COVID-19 结果的潜在作用。

结果

与精神卫生使用者相比,工作人员检测呈阳性的风险更高(比值比 [OR] 1.57 [95%置信区间 1.01-2.43;p<0.05],在考虑年龄和性别后,他们具有相同的检测呈阳性的风险(OR 1.62 [95%置信区间 0.98-2.66;p=0.06])。

结论

精神卫生使用者 COVID-19 患病率较低,这可能是由于采取了预防 COVID-19 的措施,以及抗精神病药物治疗可能在预防 SARS-CoV-2 感染方面的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2e7/9852313/ea174807a1d8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2e7/9852313/ea174807a1d8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2e7/9852313/ea174807a1d8/gr1_lrg.jpg

相似文献

1
Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study.长期精神卫生设施综合网络中精神卫生使用者和工作人员的感染、传播及 COVID-19 结局的流行病学:回顾性观察性基于人群的研究。
Schizophr Res. 2023 Apr;254:1-7. doi: 10.1016/j.schres.2023.01.020. Epub 2023 Jan 20.
2
Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.长期护理机构中实施的非药物措施以预防 SARS-CoV-2 感染及其后果:快速综述。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD015085. doi: 10.1002/14651858.CD015085.pub2.
3
Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study.英格兰长期护理机构居民和工作人员中针对 SARS-CoV-2 感染、住院和死亡的疫苗有效性持续时间(VIVALDI):一项前瞻性队列研究。
Lancet Healthy Longev. 2022 Jul;3(7):e470-e480. doi: 10.1016/S2666-7568(22)00147-7. Epub 2022 Jul 4.
4
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.在纽约州一家精神科医院系统中,长期住院的严重精神疾病患者使用精神药物与 COVID-19 感染风险之间的关联。
JAMA Netw Open. 2022 May 2;5(5):e2210743. doi: 10.1001/jamanetworkopen.2022.10743.
5
Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.作者回复:在德国首次大流行期间,工人的职业与 SARS-CoV-2 感染风险:潜在的偏见。
Scand J Work Environ Health. 2022 Sep 1;48(7):588-590. doi: 10.5271/sjweh.4061. Epub 2022 Sep 25.
6
Association between bisphosphonate use and COVID-19 related outcomes.双膦酸盐使用与 COVID-19 相关结局的关联。
Elife. 2023 Aug 3;12:e79548. doi: 10.7554/eLife.79548.
7
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
8
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
9
Risk of COVID-19 diagnosis and death in patients with mental illness: a cohort study.精神疾病患者 COVID-19 诊断和死亡风险:一项队列研究。
Epidemiol Psychiatr Sci. 2021 Oct 14;30:e68. doi: 10.1017/S2045796021000597.
10
SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.从未吸烟、曾经吸烟和当前吸烟/使用尼古丁者中的SARS-CoV-2感染:一项对4040名埃及医护人员的队列研究。
BMC Public Health. 2021 Jun 28;21(1):1243. doi: 10.1186/s12889-021-11290-x.

引用本文的文献

1
Aripiprazole as protector against COVID-19 mortality.阿立哌唑作为 COVID-19 死亡率的保护剂。
Sci Rep. 2024 May 29;14(1):12362. doi: 10.1038/s41598-024-60297-y.

本文引用的文献

1
Mental health and the SARS-CoV-2 pandemic.心理健康与2019冠状病毒病疫情
Rev Psiquiatr Salud Ment. 2020 Apr-Jun;13(2):55-56. doi: 10.1016/j.rpsm.2020.04.010. Epub 2020 May 12.
2
Antipsychotics and COVID-19: the debate goes on.抗精神病药物与新冠疫情:争论仍在继续。
Lancet Psychiatry. 2021 Dec;8(12):1030. doi: 10.1016/S2215-0366(21)00396-5.
3
Risk of COVID-19 diagnosis and death in patients with mental illness: a cohort study.精神疾病患者 COVID-19 诊断和死亡风险:一项队列研究。
Epidemiol Psychiatr Sci. 2021 Oct 14;30:e68. doi: 10.1017/S2045796021000597.
4
[COVID-19 in Nursing Homes: a pending subject].[养老院中的新冠疫情:一个悬而未决的问题]
Enferm Clin. 2021 Feb;31:S117-S119. doi: 10.1016/j.enfcli.2020.05.015. Epub 2020 May 21.
5
Can antipsychotic use protect from COVID-19?使用抗精神病药物能预防新型冠状病毒肺炎吗?
Schizophr Res. 2021 Oct;236:1-2. doi: 10.1016/j.schres.2021.07.035. Epub 2021 Jul 30.
6
The role of antipsychotics against COVID-19: A topic for debate.抗精神病药物对新型冠状病毒肺炎的作用:一个有待辩论的话题。
Schizophr Res. 2021 Sep;235:5-6. doi: 10.1016/j.schres.2021.07.003. Epub 2021 Jul 8.
7
Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.精神障碍与 COVID-19 相关死亡率、住院和重症监护病房入院风险:系统评价和荟萃分析。
Lancet Psychiatry. 2021 Sep;8(9):797-812. doi: 10.1016/S2215-0366(21)00232-7. Epub 2021 Jul 17.
8
An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.对正在接受严重精神疾病治疗的患者使用抗精神病药物对SARS-CoV-2可能产生的保护作用的分析。
Schizophr Res. 2021 Jul;233:99-100. doi: 10.1016/j.schres.2021.06.019. Epub 2021 Jun 23.
9
Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.养老院内 COVID-19 疫情的演变和影响:英国一个地理区域内 189 家养老院的人群分析。
Lancet Healthy Longev. 2020 Oct;1(1):e21-e31. doi: 10.1016/S2666-7568(20)30012-X. Epub 2020 Oct 20.
10
Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis.通过基因组分析确定阿立哌唑作为治疗新冠肺炎的候选药物。
Front Pharmacol. 2021 Mar 2;12:646701. doi: 10.3389/fphar.2021.646701. eCollection 2021.